Evidence map›Paper›PMID 40854970›Full record

ArticleScientific reports2025

Network toxicology and molecular docking elucidate the hepatotoxic and carcinogenic mechanisms of potassium sorbate validated by in vitro assays.

Yueyue Li, Weiqi Dai, Jingjing Li, Wenhui Mo, Xuanfu Xu

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yueyue LiDepartment of Gastroenterology, Shidong Hospital of Shanghai, Shanghai, 200438, China.
Weiqi DaiDepartment of Gastroenterology, Shidong Hospital of Shanghai, Shanghai, 200438, China.
Jingjing LiDepartment of Gastroenterology, Shidong Hospital of Shanghai, Shanghai, 200438, China.
Wenhui MoDepartment of Gastroenterology, Shidong Hospital of Shanghai, Shanghai, 200438, China. wugui502812@sina.com.
Xuanfu XuDepartment of Gastroenterology, Shidong Hospital of Shanghai, Shanghai, 200438, China. shuanfusky@163.com.

Funding

Yangpu District Municipal Commission and Science and Technology Commission No. YPM202117
6 · The paper itself

Abstract

Potassium sorbate is a preservative widely used in various industrial products, and its potential toxicity and environmental risks are worthy of further exploration. This study provides a novel elucidation of the ecological toxicity mechanism of potassium sorbate, supported by in vitro cell model validation, thereby offering system-level to molecular-level analysis for the risk assessment and management of food additives. A total of 124 and 106 potential targets for hepatotoxicity and carcinogenicity were identified, respectively, and protein-protein interaction networks and Cytoscape were used to determine the hub genes associated with the toxicity of potassium sorbate. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis revealed that the pathways induced by potassium sorbate were associated with cancer-related chemicals and pathways. Molecular docking results showed that potassium sorbate had high degree of affinity with the hub targets, which, combined with in vitro cell line validation, further supported the mechanism of action of potassium sorbate in the regulation of hepatocyte injury, tumor cell proliferation, and apoptosis. This study provides a novel perspective on the toxicity of potassium sorbate, and offers a theoretical basis for its safety assessment and risk management in clinical applications.

Indexed as

CarcinogensHepatocytesMolecular Docking SimulationSorbic AcidApoptosisCell Line, TumorCell ProliferationHumansProtein Interaction MapsCarcinogensSorbic AcidCarcinogenicityHepatotoxicityIn vitroMolecular dockingNetwork toxicologyPotassium sorbate

Identifiers

PMID40854970
PMCPMC12379242

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.